BiotechTube

Etodolac Extended Release Tablets USP 600mg + Etodolac Extended Release Tablets 600mg

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fasting

Conditions

Fasting

Trial Timeline

Dec 1, 2012 → Jan 1, 2013

NCT ID
NCT01831687

About Etodolac Extended Release Tablets USP 600mg + Etodolac Extended Release Tablets 600mg

Etodolac Extended Release Tablets USP 600mg + Etodolac Extended Release Tablets 600mg is a phase 1 stage product being developed by Ipca Laboratories for Fasting. The current trial status is completed. This product is registered under clinical trial identifier NCT01831687. Target conditions include Fasting.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT01831687Phase 1Completed
NCT01827865Phase 1Completed

Competing Products

20 competing products in Fasting

See all competitors
ProductCompanyStageHype Score
Lamotrigine Tablets 25 mg + LamotrigineIpca LaboratoriesPhase 1
33
Metformin Hydrochloride Extended-Release Tablets USP 750 mg + GLUCOPHAGE®XRIpca LaboratoriesPhase 1
33
Ondansetron Tablets USP 8 mg + Ondansetron HydrochlorideIpca LaboratoriesPhase 1
33
Metformin Hydrochloride Extended-Release Tablets USP 750 + GLUCOPHAGE®XR tablet 750 mgIpca LaboratoriesPhase 1
33
Quetiapine Fumarate Tablets 25 mg + Quetiapine FumarateIpca LaboratoriesPhase 1
33
Metoprolol Succinate ER Tablets 50 mg + 'TOPROL-XL®' ER Tablets 50 mgIpca LaboratoriesPhase 1
33
Etodolac Capsules USP 300 mg + EtodolacIpca LaboratoriesPhase 1
33
Risperidone Tablet 1 mg + RisperidoneIpca LaboratoriesPhase 1
33
Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide TabletsIpca LaboratoriesPhase 1
33
Allopurinol + AllopurinolIpca LaboratoriesPhase 1
33
Levocetirizine Dihydrochloride 5 mg TabletsIpca LaboratoriesPhase 1
33
Carvedilol Tablets USP 12.5 mg + CarvedilolIpca LaboratoriesPhase 1
33
Metoprolol Succinate ER Tablet 200 mg + 'TOPROL-XL®' ER Tablets 200 mgIpca LaboratoriesPhase 1
33
Etodolac Tablets USP 500mg + Etodolac Tablets USP 500 mgIpca LaboratoriesPhase 1
33
Etodolac Extended Release Tablets USP 600mg + Etodolac Extended Release Tablets 600mgIpca LaboratoriesPhase 1
33
Bisoprolol Fumarate Tablet 10 mg + BisoprololIpca LaboratoriesPhase 1
33
Lisinopril Tablets 40 mg + LisinoprilIpca LaboratoriesPhase 1
33
r-metHuLeptinAmgenPhase 1/2
40
r-metHuLeptinAmgenPhase 1
32
OlanzapineDr. Reddy's LaboratoriesPhase 1
30

Other Products from Ipca Laboratories

Metoprolol Succinate ER Tablets 50 mg + 'TOPROL-XL®' ER Tablets 50 mgPhase 1
33
Indomethacin Extended-Release Capsules USP 75 mg + Indomethacin Extended Release Capsules USP 75 mgPhase 1
33
Ondansetron Tablets USP 8 mg + Ondansetron HydrochloridePhase 1
33
Etodolac Capsules USP 300 mg + EtodolacPhase 1
33
Risperidone Tablet 1 mg + RisperidonePhase 1
33